Specifically, mixed granulocytic (>2% sputum eosinophils and >64% sputum neutrophils) asthma patients with anti-MARCO IgG antibodies had higher risk of subsequent asthma exacerbation triggered by infection. This evidence concerns the gene MARCO and asthma.